Chester County News and Community Website
WASHINGTON, D.C. — The following quote is attributed to Theresa M. Michele, M.D., director of the Office of Nonprescription Drugs in the FDA’s Center for Drug Evaluation and Research:
Read More
BERWYN, PA — Virpax® Pharmaceuticals, Inc. (NASDAQ: VRPX) this week announced that it has received a written pre-investigational new drug (pre-IND) response from the U.S. Food and Drug Administration (FDA) …
Read More BERWYN, PA — Virpax Pharmaceuticals Inc. (NASDAQ: VRPX) has provided a progress update on its pipeline of product candidates following the Company’s initial public offering (the “IPO”) in mid-February of …
Read More BERWYN, PA — Virpax Pharmaceuticals, Inc. (NASDAQ: VRPX), announced that the Investigational New Drug (IND) Application enabling studies for Envelta™ being performed under a Cooperative Research and Development Agreement (CRADA) …
Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration and the U.S. Centers for Disease Control and Prevention have determined that the recommended pause regarding the use of the Janssen …
Read More COATESVILLE, PA — Following the recommendation of the Centers for Disease Control & Prevention (CDC) and the Food and Drug Administration (FDA), the Coatesville Veterans Affairs Medical Center continues to …
Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration has issued warning letters to two companies for selling products labeled as containing cannabidiol (CBD) in ways that violate the Federal …
Read More
KENNETT SQUARE, PA — Genesis HealthCare (NYSE: GEN), one of the largest post-acute care providers in the United States, announced this week that 84% of its skilled nursing residents and …
Read More
SILVER SPRING, MD — The U.S. Food and Drug Administration is taking important actions to help accelerate the development of prevention and treatment options for COVID-19 by providing new guidance …
Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration announced it is requesting manufacturers withdraw all prescription and over-the-counter (OTC) ranitidine drugs from the market immediately.
Read More